nVNS, CBD, and SoC for Persistent Post-Traumatic Headache
NCT: NCT07624279 · NOT_YET_RECRUITING
NCT IDNCT07624279
StatusNOT_YET_RECRUITING
Start Date2026-06-01
Completion2028-07-01
SponsorAmerican Society of Pain and Neuroscience, Inc. (OTHER)
First posted
Last updated
Brief Summary
Do cannabidiol (CBD) or vagus nerve stimulation reduce the frequency of persistent post-traumatic headache more than traditional oral headache medications?
Frequently Asked Questions
What is nVNS, CBD, and SoC for Persistent Post-Traumatic Headache?
nVNS, CBD, and SoC for Persistent Post-Traumatic Headache is a clinical trial registered under NCT07624279. Current status: NOT_YET_RECRUITING.
What is the status of NCT07624279?
The current status of NCT07624279 (nVNS, CBD, and SoC for Persistent Post-Traumatic Headache) is: NOT_YET_RECRUITING.
When did nVNS, CBD, and SoC for Persistent Post-Traumatic Headache start?
nVNS, CBD, and SoC for Persistent Post-Traumatic Headache started on 2026-06-01.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.